Progeria, rapamycin and normal aging: recent breakthrough
A recent discovery that rapamycin suppresses a pro-senescent phenotype in progeric cells not only suggests a non-toxic therapy for progeria but also implies its similarity with normal aging. For one, rapamycin is also known to suppress aging of regular human cells. Here I discuss four potential scen...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Impact Journals LLC
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181168/ |